Troikaa Pharmaceuticals Limited

Troikaa Pharmaceuticals Limited - pharma in Ahmadabad City, Gujarat, India. FY 2026 financials and compliance.
CIN U24100GJ1994PLC022162 Incorporated 31 May 1994 ROC Ahmedabad HQ Ahmadabad City, Gujarat, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹1,088.44 Cr
▲ 12.00% YoY
EBITDA · FY 2025
*****
▼ 1.00% YoY
Net profit · FY 2025
*****
▼ 95.00% YoY
Authorised capital
₹68 Cr
Registered with MCA
Paid-up capital
₹62.55 Cr
Issued & subscribed
Open charges
₹817.99 Cr
Satisfied ₹111.56 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
3,558
Latest available

About Troikaa Pharmaceuticals Limited

Data last updated: 30 December 2025

Troikaa Pharmaceuticals Limited is a public limited company based in Ahmadabad City, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 May 1994, the company has been in operation for over 32 years.

Registered with ROC Ahmedabad under CIN U51909GJ1994PLC022162.

Capital: an authorised share capital of ₹68 Cr and a paid-up capital of ₹62.55 Cr. Formerly known as Troikaa Exports Limited and Troikaa Exports Pvt Ltd. It is led by directors including Kush Milan Patel and Achyutkumar Dadubhai Patel.

Last AGM: 06 August 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmadabad City, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,088.44 Cr, a growth of 12% compared to the previous year.

The company has a workforce of approximately 3,558 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹817.99 Cr and satisfied charges of ₹111.56 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website troikaa.com.

Company Details of Troikaa Pharmaceuticals Limited
CIN U24100GJ1994PLC022162
Registration Number 022162
Incorporation Date 31 May 1994
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 06 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Ketan Rajnikant Patel Managing Director Milan Rajnikant Patel Managing Director Kush Milan Patel Whole-Time Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
  • Registered Address
    Troikaa House Commerce House – 1, Satya Marg, Ahmadabad City, Gujarat, India – 380054
  • Industry
    Pharma, Drug Formulation & Development
Company report
Troikaa Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Troikaa Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Troikaa Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Troikaa Pharmaceuticals Limited

Troikaa Pharmaceuticals Limited has undergone 3 name changes throughout its history. The company was previously known as Troikaa Exports Limited, Troikaa Exports Pvt Ltd, and Troikaa Exports Ltd. The current legal name is Troikaa Pharmaceuticals Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Troikaa Pharmaceuticals Limited Current
Troikaa Exports Limited Previous
Troikaa Exports Pvt Ltd Previous
Troikaa Exports Ltd Previous

CIN History of Troikaa Pharmaceuticals Limited

Troikaa Pharmaceuticals Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100GJ1994PLC022162, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24100GJ1994PLC022162 Current
U51909GJ1994PLC022162 Previous
U51909GJ1994PTC022162 Previous

Business Activity of Troikaa Pharmaceuticals Limited

Troikaa Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Board of Directors of Troikaa Pharmaceuticals Limited

Troikaa Pharmaceuticals Limited is currently managed by 14 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kush Milan Patel
Also directs: Troikaa Pharmachem Private Limited
Whole-Time Director 08 Aug 2025 0 Years 11 Months Current
Achyutkumar Dadubhai Patel
Also directs: Troikaa Pharmachem Private Limited
Whole-Time Director 24 Oct 2015 10 Years 8 Months Current
Subir Kumar Das
Also directs: Troikaa Pharmachem Private Limited, Transformers And Rectifiers (India) Limited, M & B Engineering Limited and 2 more
Director 03 Feb 2020 6 Years 5 Months Current
Asheel Ketan Patel
Also directs: Troikaa Pharmachem Private Limited
Whole-Time Director 01 Apr 2021 5 Years 3 Months Current
Nisheel Ketan Patel
Also directs: Troikaa Pharmachem Private Limited
Whole-Time Director 08 Aug 2025 0 Years 11 Months Current
Prakash Jayantilal Shah Director 08 Aug 2023 2 Years 11 Months Current
Showing 6 of 14 current directors. View all directors

Financials of Troikaa Pharmaceuticals Limited FY 2025 filings available

Troikaa Pharmaceuticals Limited reported revenue of ₹1,088.44 Cr (up 12% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹1,088.44 Cr ▲ 12%
Profit
***** ▼ -95%
EBITDA
***** ▼ -1%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Troikaa Pharmaceuticals Limited

Open charges
₹817.99 Cr
Satisfied charges
₹111.56 Cr
Breakdown by lending institutions
Others₹661.37 Cr
Standard Chartered Bank₹70.31 Cr
Hdfc Bank Limited₹47.72 Cr
Bank of Baroda₹38.58 Cr
Latest charge details
DateLenderAmountStatus
17 Oct 2025 Hdfc Bank Limited ₹33.49 Lakh Open
14 Aug 2025 Hdfc Bank Limited ₹17.28 Lakh Open
17 Jun 2025 Hdfc Bank Limited ₹17.28 Lakh Open
15 May 2025 Hdfc Bank Limited ₹16.41 Lakh Open
13 Mar 2025 Others ₹18.6 Cr Open

Total charge records: 45 View all charges

Employees and EPFO Compliance at Troikaa Pharmaceuticals Limited

View historical data on people associated with Troikaa Pharmaceuticals Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Troikaa Pharmaceuticals Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Troikaa Pharmaceuticals Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Troikaa Pharmaceuticals Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Troikaa Pharmaceuticals Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Troikaa Pharmaceuticals Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Troikaa Pharmaceuticals Limited

MSME Payment Delays by Troikaa Pharmaceuticals Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Troikaa Pharmaceuticals Limited

Subsidiaries & Group Companies of Troikaa Pharmaceuticals Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Troikaa Pharmaceuticals Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Troikaa Pharmaceuticals Limited

MCA Filings & Documents of Troikaa Pharmaceuticals Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Troikaa Pharmaceuticals Limited

Charges
17 Oct 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.33 Cr with Charge ID 101172346 was registered on 17 Oct 2025.
Charges
26 Sep 2025
A charge with Others of Rs. 60.00 Cr registered on 27 Sep 2007 with Charge ID 10071482 was modified on 26 Sep 2025.
Charges
26 Aug 2025
A charge registered on 30 Jan 2021 via Charge ID 100423839 with Hdfc Bank Limited was fully satisfied on 26 Aug 2025.
Charges
26 Aug 2025
A charge registered on 30 Jan 2021 via Charge ID 100424043 with Hdfc Bank Limited was fully satisfied on 26 Aug 2025.
Charges
26 Aug 2025
A charge registered on 26 Aug 2014 via Charge ID 10558452 with Hdfc Bank Limited was fully satisfied on 26 Aug 2025.
Charges
14 Aug 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 101140163 was registered on 14 Aug 2025.

Recent News on Troikaa Pharmaceuticals Limited

Frequently Asked Questions about Troikaa Pharmaceuticals Limited

Troikaa Pharmaceuticals Limited is an active public limited company in the pharma sector based in Ahmadabad City, Gujarat, India. It was incorporated on 31 May 1994 (32+ years old) and is registered under CIN U24100GJ1994PLC022162. The company has 3,558 employees.

Troikaa Pharmaceuticals Limited reported revenue of ₹1,088.44 Cr for FY 2025 (up 12.00% YoY).

The current directors of Troikaa Pharmaceuticals Limited are:

The primary industry of Troikaa Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Troikaa Pharmaceuticals Limited can be reached at the registered office: Troikaa House Commerce House – 1, Satya Marg, Ahmadabad City, Gujarat, India – 380054, or through the website troikaa.com.

The authorised capital is ₹68 Cr, and the paid-up capital is ₹62.55 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available